Sartorius Stedim Biotech S.A.
SDMHF
$235.80
$0.800.34%
OTC PK
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 845.52M | 800.86M | 720.53M | 760.32M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 845.52M | 800.86M | 720.53M | 760.32M | |
| Cost of Revenue | 454.31M | 463.70M | 417.76M | 430.64M | |
| Gross Profit | 391.21M | 337.17M | 302.77M | 329.68M | |
| SG&A Expenses | 189.53M | 187.18M | 171.17M | 170.38M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | 18.84M | -7.25M | 12.86M | 9.04M | |
| Total Operating Expenses | 699.12M | 683.18M | 642.81M | 647.95M | |
| Operating Income | 146.41M | 117.68M | 77.73M | 112.37M | |
| Income Before Tax | 104.98M | 43.60M | 39.03M | 70.39M | |
| Income Tax Expenses | 27.24M | -5.76M | 10.11M | 18.08M | |
| Earnings from Continuing Operations | 77.74M | 49.35M | 28.91M | 52.31M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -746.20K | -879.50K | -1.08M | |
| Net Income | 77.74M | 48.61M | 28.03M | 51.23M | |
| EBIT | 146.41M | 117.68M | 77.73M | 112.37M | |
| EBITDA | 234.82M | 130.69M | 161.50M | 192.56M | |
| EPS Basic | 0.78 | 0.50 | 0.29 | 0.54 | |
| Normalized Basic EPS | 0.66 | 0.50 | -- | 0.45 | |
| EPS Diluted | 0.78 | 0.50 | 0.29 | 0.54 | |
| Normalized Diluted EPS | 0.66 | 0.50 | -- | 0.45 | |
| Average Basic Shares Outstanding | 99.28M | 97.18M | 98.08M | 95.20M | |
| Average Diluted Shares Outstanding | 99.28M | 97.18M | 98.08M | 95.20M | |
| Dividend Per Share | -- | 0.74 | -- | -- | |
| Payout Ratio | 97.96% | 0.00% | -- | 140.97% | |